Company Filing History:
Years Active: 2015-2019
Title: Innovations of Hiroyuki Yanai
Introduction
Hiroyuki Yanai is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of anti-tumor antibodies. With a total of five patents to his name, Yanai's work has the potential to impact cancer treatment significantly.
Latest Patents
Yanai's latest patents include the development of an anti-human TROP-2 antibody that exhibits antitumor activity in vivo. This invention provides an antibody that specifically reacts with hTROP-2 and demonstrates anti-tumor activity in vivo, particularly as a humanized antibody. Additionally, it includes a hybridoma that produces the aforementioned antibody, a conjugate of the antibody and a drug, a pharmaceutical composition for diagnosing or treating tumors, a method for detecting tumors, and a kit for detecting or diagnosing tumors. Another patent focuses on a similar anti-human TROP-2 antibody with anti-tumor activity in vivo, emphasizing the importance of this research in cancer diagnostics and treatment.
Career Highlights
Throughout his career, Yanai has worked with various companies, including Chiome Bioscience Inc. and Livtech, Inc. His experience in these organizations has allowed him to collaborate with other experts in the field and further his research in antibody development.
Collaborations
Some of Yanai's notable coworkers include Koji Nakamura and Toru Kanke. Their collaboration has contributed to the advancement of innovative solutions in biotechnology.
Conclusion
Hiroyuki Yanai's work in developing anti-tumor antibodies showcases his dedication to advancing cancer treatment. His patents reflect a commitment to innovation in the field of biotechnology, which may lead to significant improvements in patient care.